300015 爱尔眼科
已收盘 08-11 15:00:00
资讯
新帖
简况
探寻价值，洞见未来！ 证券之星“发现中国好公司”活动在上海爱尔眼科医院成功举行
证券之星 · 08-08 12:21
探寻价值，洞见未来！ 证券之星“发现中国好公司”活动在上海爱尔眼科医院成功举行
中证互联网医疗主题指数下跌1.42%，前十大权重包含爱尔眼科等
金融界 · 08-08 11:08
中证互联网医疗主题指数下跌1.42%，前十大权重包含爱尔眼科等
大摩：华润医疗上半年初步利润逊预期 评级“减持” 目标价3港元
智通财经 · 08-05
大摩：华润医疗上半年初步利润逊预期 评级“减持” 目标价3港元
摩根士丹利发表研究报告指出华润医疗发布今年上半年利润警告普通股股东应占净利润预计按年下降20%至25%。若剔除与燕化IO
智通财经 · 08-05
摩根士丹利发表研究报告指出华润医疗发布今年上半年利润警告普通股股东应占净利润预计按年下降20%至25%。若剔除与燕化IO
大行评级｜里昂：中国医疗健康行业流动性及基本面持续改善，偏好领先大型药厂
格隆汇 · 08-05
大行评级｜里昂：中国医疗健康行业流动性及基本面持续改善，偏好领先大型药厂
27笔！商办和园区大宗成交盘点
选址960 · 08-04
27笔！商办和园区大宗成交盘点
高盛：“银发群体” 崛起带动高端自付治疗项目增长 关注其中受益的主要股票
智通财经 · 07-31
高盛：“银发群体” 崛起带动高端自付治疗项目增长 关注其中受益的主要股票
爱尔眼科：专注主业提供多层次眼科诊疗服务
证券之星 · 07-29
爱尔眼科：专注主业提供多层次眼科诊疗服务
高盛集团上调爱尔眼科、智飞生物评级
格隆汇 · 07-28
高盛集团上调爱尔眼科、智飞生物评级
爱尔眼科股价上涨1.24% 医疗服务板块表现分化
金融界 · 07-08
爱尔眼科股价上涨1.24% 医疗服务板块表现分化
“理性投资伴我行”国泰海通证券投资者走进上市公司——爱尔眼科
全景财经 · 06-29
“理性投资伴我行”国泰海通证券投资者走进上市公司——爱尔眼科
爱尔眼科（300015）2021年限制性股票激励计划第四期解禁条件达成，19.39万股暂不上市
中访网财观 · 06-16
爱尔眼科（300015）2021年限制性股票激励计划第四期解禁条件达成，19.39万股暂不上市
爱尔眼科，暂无香港上市计划
瑞恩资本Ryanbe... · 05-22
爱尔眼科，暂无香港上市计划
爱尔眼科董事长谈“接班人”与赴港上市，“行业回暖了，爱尔更健康了”
东方财富 · 05-21
爱尔眼科董事长谈“接班人”与赴港上市，“行业回暖了，爱尔更健康了”
新股消息 | 爱尔眼科(300015.SZ)董事长陈邦：公司近期暂时无港股上市打算
智通财经 · 05-20
新股消息 | 爱尔眼科(300015.SZ)董事长陈邦：公司近期暂时无港股上市打算
爱尔眼科(300015.SZ)公开摘牌取得广晟数码60%股权及特定债权项目
智通财经 · 05-13
爱尔眼科(300015.SZ)公开摘牌取得广晟数码60%股权及特定债权项目
爱尔眼科最新公告：子公司公开摘牌获得广晟数码60%股权及特定债权项目
证券之星 · 05-13
爱尔眼科最新公告：子公司公开摘牌获得广晟数码60%股权及特定债权项目
爱尔眼科新注册《爱尔医疗云平台1.0》项目的软件著作权
证券之星 · 05-10
爱尔眼科新注册《爱尔医疗云平台1.0》项目的软件著作权
爱尔眼科：2024年并购的医院多为地县级医院，院龄较短、收入体量较小
证券之星 · 05-07
爱尔眼科：2024年并购的医院多为地县级医院，院龄较短、收入体量较小
爱尔眼科624万限售股解除限售条件达成 暂不上市至11月5日
财中社 · 05-06
爱尔眼科624万限售股解除限售条件达成 暂不上市至11月5日
加载更多
公司概况
公司名称：
爱尔眼科医院集团股份有限公司
所属行业：
卫生
上市日期：
2009-10-30
主营业务：
爱尔眼科医院集团股份有限公司的主营业务是各类眼科疾病诊疗、手术服务与医学验光配镜。公司的主要产品是屈光项目、白内障项目、眼前段项目、眼后段项目、视光服务项目。
发行价格：
28.00
{"stockData":{"symbol":"300015","market":"SZ","secType":"STK","nameCN":"爱尔眼科","latestPrice":12.98,"timestamp":1754895816000,"preClose":12.76,"halted":0,"volume":77962705,"delay":0,"changeRate":0.0172,"floatShares":7931000000,"shares":9325000000,"eps":0.3975,"marketStatus":"已收盘","change":0.22,"latestTime":"08-11 15:00:00","open":12.76,"high":13.02,"low":12.72,"amount":1006000000,"amplitude":0.0235,"askPrice":12.98,"askSize":6542,"bidPrice":12.97,"bidSize":2918,"shortable":0,"etf":0,"ttmEps":0.3975,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1754962200000},"marketStatusCode":5,"adr":0,"adjPreClose":12.76,"symbolType":"stock","openAndCloseTimeList":[[1754875800000,1754883000000],[1754888400000,1754895600000]],"highLimit":14.04,"lowLimit":11.48,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":9325396670,"isCdr":false,"pbRate":5.45,"roa":"--","peRate":32.654088,"roe":"4.93%","epsLYR":0.3847,"committee":-0.359129,"marketValue":121044000000,"turnoverRate":0.0098,"status":0,"floatMarketCap":102944000000},"requestUrl":"/m/hq/s/300015","defaultTab":"news","newsList":[{"id":"2557286524","title":"探寻价值，洞见未来！ 证券之星“发现中国好公司”活动在上海爱尔眼科医院成功举行","url":"https://stock-news.laohu8.com/highlight/detail?id=2557286524","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557286524?lang=zh_cn&edition=full","pubTime":"2025-08-08 20:21","pubTimestamp":1754655687,"startTime":"0","endTime":"0","summary":"2025年8月8日，由权威财经平台证券之星主办的“发现中国好公司”——走进上市公司系列活动在上海爱尔眼科医院成功举行。本次活动以“探寻价值，洞见未来”为主题，通过实地探访、高管对话、沉浸式体验三维一体深度调研，旨在进一步增进投资者对爱尔眼科的全面了解，加强公司与投资者沟通交流的紧密度。证券之星代表表示，本次活动为“发现中国好公司”树立了新标杆——唯有穿透数据，直面产业现场，才能捕捉真正的价值成长基因。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2025080800035242.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0200","BK0028","161027","BK0077","LU1242518857.USD","LU1820825898.SGD","BK0114","LU0979878070.USD","BK0012","300015","BK0096","LU1146622755.USD","BK0188","BK0196","BK0113","LU1242518931.SGD","BK0236"],"gpt_icon":0},{"id":"2557524596","title":"中证互联网医疗主题指数下跌1.42%，前十大权重包含爱尔眼科等","url":"https://stock-news.laohu8.com/highlight/detail?id=2557524596","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557524596?lang=zh_cn&edition=full","pubTime":"2025-08-08 19:08","pubTimestamp":1754651337,"startTime":"0","endTime":"0","summary":"数据统计显示，中证互联网医疗主题指数近一个月上涨6.19%，近三个月上涨6.77%，年至今上涨18.05%。据了解，中证互联网医疗主题指数选取为医疗信息化、智能化提供硬件、软件或服务的代表性公司作为样本，以反映互联网医疗主题相关公司的整体表现。从中证互联网医疗主题指数持仓样本的行业来看，医药卫生占比63.81%、信息技术占比31.17%、通信服务占比5.02%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080819251894d7944d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080819251894d7944d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0077","BK0200","BK0028","300015","BK0114","BK0113","BK0188","BK0209","688139","LU1242518857.USD","BK0196","BK0185","BK0236","603108","BK0096","LU1146622755.USD","603233","LU1242518931.SGD","LU1820825898.SGD","LU0979878070.USD","BK0012","688246"],"gpt_icon":0},{"id":"2557369096","title":"大摩：华润医疗上半年初步利润逊预期 评级“减持” 目标价3港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557369096","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557369096?lang=zh_cn&edition=full","pubTime":"2025-08-05 15:47","pubTimestamp":1754380020,"startTime":"0","endTime":"0","summary":"摩根士丹利发布研报称，华润医疗(01515)发布今年上半年利润警告，普通股股东应占净利润预计同比下降20%至25%。若剔除与“燕化IOT协议”相关的2.1亿元人民币补偿，基础业务利润将同比下降55% ...","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20250805/c670144656.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["LU1242518931.SGD","LU1820825898.SGD","LU1242518857.USD","300015","BK0028","BK0114","BK0012","BK0196","BK0077","BK0188","BK0096","LU0979878070.USD","BK0113","LU1146622755.USD","BK0200","BK0236"],"gpt_icon":0},{"id":"2557352311","title":"摩根士丹利发表研究报告指出华润医疗发布今年上半年利润警告普通股股东应占净利润预计按年下降20%至25%。若剔除与燕化IO","url":"https://stock-news.laohu8.com/highlight/detail?id=2557352311","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557352311?lang=zh_cn&edition=full","pubTime":"2025-08-05 13:05","pubTimestamp":1754370318,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0106261372.USD","BK1597","BK4534","02273","IOT","LU0267386448.USD","BK0077","LU0098860793.USD","BK4613","LU1732800096.USD","LU2089284900.SGD","01515","IE00BKVL7J92.USD","LU1074936037.SGD","BK0188","BK1209","IE00BZ1G4Q59.USD","BK4504","300015","LU0795875169.SGD","BK0200","LU1732799900.SGD","BK0012","BK4516","LU0158827781.USD","BK4127","LU1668664300.SGD","LU2271345857.HKD","LU2347655156.SGD","LU2357305700.SGD","LU2111349929.HKD","LU0795875086.SGD","BK1570","BK0096","06078","LU1363072403.SGD","LU1720051017.SGD","LU2028103732.USD","LU0106831901.USD","LU1989772923.USD","BK4585","LU1146622755.USD","DIP","LU2023251221.USD","01951","BK0236","LU0912757837.SGD","LU0979878070.USD","LU0737861772.HKD","BK4588"],"gpt_icon":0},{"id":"2557835699","title":"大行评级｜里昂：中国医疗健康行业流动性及基本面持续改善，偏好领先大型药厂","url":"https://stock-news.laohu8.com/highlight/detail?id=2557835699","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557835699?lang=zh_cn&edition=full","pubTime":"2025-08-05 10:29","pubTimestamp":1754360961,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["IE00BVYPNQ40.USD","600276","00867","01276","ZTmain","GOVT","SHY","IE00B543WZ88.USD","LU2125910500.SGD","LU2242644610.SGD","LU1807302812.USD","300015","UTRE","603259","159992","03692","300347","IE00BGHQDM52.EUR","09926","300765","01093","01099","UBmain","603233","ZFmain","03347","TNmain","ZNmain","IEI","IEF","000963","TLT","LU1997244956.HKD","LU1655091616.SGD","UFIV","BND","02359","LU0405327148.USD","159760","LU1960683339.HKD","USVN","06978","01477","LU0708995583.HKD","UTHY","ZBmain","UTWY","LU0417516571.SGD","IE00BPRC5H50.USD","BK0200"],"gpt_icon":0},{"id":"2556386866","title":"27笔！商办和园区大宗成交盘点","url":"https://stock-news.laohu8.com/highlight/detail?id=2556386866","media":"选址960","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556386866?lang=zh_cn&edition=full","pubTime":"2025-08-04 17:30","pubTimestamp":1754299828,"startTime":"0","endTime":"0","summary":"上半年，万科、远洋、复星都有商办大宗成交。万科于2024年4月推出瘦身计划，其中包括坚决大力度推进商办等大宗资产交易，计划每年完成200亿元；根据万科披露的信息，2024年全年万科大宗交易项目54个，合计签约金额259亿元；今年上半年万科实现大宗交易签约金额64.3亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804175924a6d22767&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804175924a6d22767&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1820825898.SGD","300251","BK0098","BK0096","BK0012","BK0087","BK0077","BK0200","BK0113","BK0267","BK0083","LU0979878070.USD","LU1146622755.USD","LU1242518931.SGD","BK0231","300015","BK0236","688018","BK0114","BK0108","BK0188","BK0196","LU1242518857.USD","BK0028","BK0049"],"gpt_icon":0},{"id":"2555003687","title":"高盛：“银发群体” 崛起带动高端自付治疗项目增长 关注其中受益的主要股票","url":"https://stock-news.laohu8.com/highlight/detail?id=2555003687","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555003687?lang=zh_cn&edition=full","pubTime":"2025-07-31 11:00","pubTimestamp":1753930843,"startTime":"0","endTime":"0","summary":"高盛重点列出了覆盖范围内最有望从高端自付治疗项目增长中受益的主要股票——上调爱尔眼科、智飞生物至“买入”评级、予普瑞眼科、Straumann“买入”评级、升通策医疗评级至“中性”。2024 年，该群体虽仅占50岁以上总人口的3%，却贡献了该群体医疗健康支出的5%，高盛预计到2035年，这一比例将增长至13%。高盛假设在2024-2035年期间，50岁以上、净资产超过300万元人民币的群体的医疗健康支出在基准/乐观/悲观情景下的复合年增长率分别为 14%/19%/9%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073111141094c52dd0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073111141094c52dd0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0114","BK0146","LU1242518931.SGD","600763","LU1820825898.SGD","LU0979878070.USD","LU1064131003.USD","BK0012","BK0188","BK0113","BK0284","LU1242518857.USD","BK0046","BK0200","BK0196","300122","301239","BK0077","BK0096","BK0236","LU1328615791.USD","BK0048","LU2580892789.USD","LU1146622755.USD","LU1064130708.USD","BK0028","300015","BK0239","LU2580892862.HKD","LU2148510915.USD"],"gpt_icon":0},{"id":"2555036918","title":"爱尔眼科：专注主业提供多层次眼科诊疗服务","url":"https://stock-news.laohu8.com/highlight/detail?id=2555036918","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555036918?lang=zh_cn&edition=full","pubTime":"2025-07-29 16:48","pubTimestamp":1753778902,"startTime":"0","endTime":"0","summary":"证券之星消息，爱尔眼科(300015)07月29日在投资者关系平台上答复投资者关心的问题。投资者提问：公司是否考虑在未来自主研发创新药物爱尔眼科回复：谢谢您对公司的关注。公司专注主业，为全年龄段人群提供多层次的眼科诊疗服务。公司旗下多家医院为药品临床试验管理规范（GCP）基地，持续关注眼科创新药物发展动态。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072900027497.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","BK0188","BK0196","BK0200","BK0028","BK0012","BK0077","BK0113","LU1242518931.SGD","LU1820825898.SGD","LU0979878070.USD","300015","BK0096","BK0236","LU1146622755.USD","LU1242518857.USD"],"gpt_icon":0},{"id":"2554727264","title":"高盛集团上调爱尔眼科、智飞生物评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2554727264","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554727264?lang=zh_cn&edition=full","pubTime":"2025-07-28 17:49","pubTimestamp":1753696168,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0114","BK0046","CYB","BK0200","LU1146622755.USD","LU1328615791.USD","BK0012","BK0113","MCNHmain","LU1064131003.USD","LU2580892789.USD","BK0028","BK0239","LU0979878070.USD","BK0188","BK0196","LU2148510915.USD","LU1242518857.USD","LU1242518931.SGD","LU2580892862.HKD","UCmain","LU1064130708.USD","300122","CNHmain","300015","BK0096","BK0077","LU1820825898.SGD","MUCmain","BK0236"],"gpt_icon":0},{"id":"2550452144","title":"爱尔眼科股价上涨1.24% 医疗服务板块表现分化","url":"https://stock-news.laohu8.com/highlight/detail?id=2550452144","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550452144?lang=zh_cn&edition=full","pubTime":"2025-07-09 00:01","pubTimestamp":1751990514,"startTime":"0","endTime":"0","summary":"截至2025年7月8日15时23分，爱尔眼科股价报12.28元，较前一交易日上涨0.15元，涨幅1.24%。当日开盘价为12.12元，最高触及12.30元，最低下探12.11元，成交额6.10亿元，换手率0.63%。爱尔眼科属于医疗服务板块，公司专注于眼科医疗领域，业务涵盖屈光手术、白内障治疗、视光服务等。消息面上，自2024年11月8日至2025年7月8日期间，爱尔眼科股价表现较弱，区间跌幅达24.6%，在千亿市值股中跌幅居前。资金方面，7月8日主力资金净流入4594.33万元，占流通市值的0.05%。风险提示：市场有风险，投资需谨慎。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/07/09000151571098.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0113","LU0979878070.USD","LU1146622755.USD","LU1820825898.SGD","BK0028","LU1242518857.USD","300015","BK0196","BK0236","LU1242518931.SGD","BK0096","BK0077","BK0114","BK0200","BK0188","BK0012"],"gpt_icon":0},{"id":"2547084155","title":"“理性投资伴我行”国泰海通证券投资者走进上市公司——爱尔眼科","url":"https://stock-news.laohu8.com/highlight/detail?id=2547084155","media":"全景财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547084155?lang=zh_cn&edition=full","pubTime":"2025-06-29 22:17","pubTimestamp":1751206620,"startTime":"0","endTime":"0","summary":"“理性投资伴我行”国泰海通证券投资者走进上市公司——爱尔眼科股票代码：300015 “理性投资伴我行”国泰海通证券投资者走进上市公司——爱尔眼科，将于2025年6月30日15:00-15:50在全景网播出，敬请期待！活动嘉宾\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-06-29/doc-infcufte8337172.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1820825898.SGD","LU1146622755.USD","BK0201","BK0200","BK0184","BK0188","BK0096","BK1564","BK1147","BK0276","BK0113","BK0012","601211","02611","LU1242518857.USD","BK0028","300015","161027","BK0196","BK0236","BK0114","BK0077","LU0979878070.USD","BK0183","LU1242518931.SGD"],"gpt_icon":0},{"id":"2543608096","title":"爱尔眼科（300015）2021年限制性股票激励计划第四期解禁条件达成，19.39万股暂不上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2543608096","media":"中访网财观","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543608096?lang=zh_cn&edition=full","pubTime":"2025-06-16 20:40","pubTimestamp":1750077600,"startTime":"0","endTime":"0","summary":"来源：中访网财观中访网数据 爱尔眼科医院集团股份有限公司今日公告，其2021年限制性股票激励计划首次授予部分第四个解除限售期条件已达成。根据激励计划规定，激励对象承诺自解除限售条件达成之日起6个月内不得转让当批次股票，因此本次解禁股票暂不上市流通，禁售期将持续至2025年12月14日。监事会审议认为，本次解除限售程序符合相关规定，激励对象均满足100%解除限售条件。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/cj/2025-06-16/doc-infahqya0678092.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1146622755.USD","BK0028","BK0096","300015","BK0236","LU1820825898.SGD","LU1242518931.SGD","BK0196","LU1242518857.USD","LU0979878070.USD","BK0114","BK0012","BK0113","BK0200","BK0077","BK0188"],"gpt_icon":0},{"id":"2537995461","title":"爱尔眼科，暂无香港上市计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2537995461","media":"瑞恩资本Ryanbe...","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537995461?lang=zh_cn&edition=full","pubTime":"2025-05-22 13:16","pubTimestamp":1747890960,"startTime":"0","endTime":"0","summary":"不过，A股眼科龙头爱尔眼科于5月20日召开年度股东大会上，公司董事长陈邦表示，暂无香港上市打算。爱尔眼科暂未考虑香港上市，可能与目前估值较低也有关，爱尔眼科，于2021年7月市值曾一度高达近3900亿元，目前约1200亿元市值较之缩水六七成。截至2024 年12月31日，爱尔眼科在境内拥有医院352家、门诊部229 家，在境外已布局163家眼科中心及诊所。截至午间收市，爱尔眼科每股报12.76元，总市值约1190.13亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/stockzmt/2025-05-22/doc-inexmhch7163144.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0012","BK0077","BK0114","LU1146622755.USD","BK0096","LU1242518931.SGD","300015","BK0113","BK0188","BK0236","LU1242518857.USD","BK0196","LU1820825898.SGD","LU0979878070.USD","BK0200","BK0028"],"gpt_icon":0},{"id":"2537934325","title":"爱尔眼科董事长谈“接班人”与赴港上市，“行业回暖了，爱尔更健康了”","url":"https://stock-news.laohu8.com/highlight/detail?id=2537934325","media":"东方财富","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537934325?lang=zh_cn&edition=full","pubTime":"2025-05-21 22:23","pubTimestamp":1747837380,"startTime":"0","endTime":"0","summary":"在5月20日召开的年度股东大会上，爱尔眼科董事长陈邦表示。爱尔眼科董事长陈邦 不止于此，爱尔眼科同时在大力培养业务团队、医生团队等关键岗位的“接班人”。实际上，爱尔眼科暂未考虑赴港上市，可能亦有眼下估值相对较低的原因。截至2024年12月末，爱尔眼科境内医院352家，门诊部229家。今年以来，爱尔眼科逐步走出了新曲线。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-05-21/doc-inexiyiw7736775.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1242518931.SGD","LU1820825898.SGD","LU1242518857.USD","300015","BK0028","BK0114","BK0012","BK0196","BK0077","BK0188","BK0096","LU0979878070.USD","BK0113","LU1146622755.USD","BK0200","BK0236"],"gpt_icon":1},{"id":"2536699876","title":"新股消息 | 爱尔眼科(300015.SZ)董事长陈邦：公司近期暂时无港股上市打算","url":"https://stock-news.laohu8.com/highlight/detail?id=2536699876","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536699876?lang=zh_cn&edition=full","pubTime":"2025-05-20 16:12","pubTimestamp":1747728749,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，5月20日，爱尔眼科董事长陈邦在举行的公司2024年度股东大会上，回答投资者“是否考虑港股上市”的提问时表示，公司近期暂时没有这个打算。数据显示，爱尔眼科第一季度营业收入60.26亿元，同比增长15.97%;归属于上市公司股东的净利润10.50亿元，同比增长16.71%;归属于上市公司股东的扣除非经常性损益的净利润10.60亿元，同比增长25.78%;基本每股收益0.1136元/股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1295271.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0113","HSTECH","300015","BK0236","BK0096","BK0200","BK0188","BK0012","LU1820825898.SGD","BK0196","LU0979878070.USD","BK0028","BK0114","YANG","HSCEI","LU1146622755.USD","LU1242518857.USD","LU1242518931.SGD","BK0077","BK4614"],"gpt_icon":1},{"id":"2535270485","title":"爱尔眼科(300015.SZ)公开摘牌取得广晟数码60%股权及特定债权项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2535270485","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535270485?lang=zh_cn&edition=full","pubTime":"2025-05-14 00:10","pubTimestamp":1747152603,"startTime":"0","endTime":"0","summary":"智通财经APP讯， 爱尔眼科(300015.SZ)发布公告，公司的全资子公司深圳滨海爱尔眼科医院(以下简称“深圳滨海爱尔”)通过广东联合产权交易中心公开摘牌获得深圳广晟数码技术有限公司60%股权及特定债权项目，本次交易以自有资金支付，交易价格为人民币6.5亿元。标的公司的资产包括“广晟科创大厦”，将作为深圳滨海爱尔的长期医疗用房。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1292787.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"爱尔眼科(300015.SZ)公开摘牌取得广晟数码60%股权及特定债权项目","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0096","BK0188","LU1820825898.SGD","BK0114","BK0077","BK0113","300015","BK0196","BK0200","LU1146622755.USD","LU1242518857.USD","LU1242518931.SGD","BK0012","BK0028","BK0236","LU0979878070.USD"],"gpt_icon":0},{"id":"2535777419","title":"爱尔眼科最新公告：子公司公开摘牌获得广晟数码60%股权及特定债权项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2535777419","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535777419?lang=zh_cn&edition=full","pubTime":"2025-05-13 22:20","pubTimestamp":1747146026,"startTime":"0","endTime":"0","summary":"爱尔眼科(300015.SZ)公告称，公司全资子公司深圳滨海爱尔眼科医院通过广东联合产权交易中心公开摘牌获得深圳广晟数码技术有限公司60%股权及特定债权项目，交易价格为6.496亿元。标的公司的资产包括“广晟科创大厦”，将作为深圳滨海爱尔的长期医疗用房。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025051300038207.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300015","BK0012","BK0028","BK0200","LU1146622755.USD","LU0979878070.USD","LU1242518857.USD","BK0113","LU1820825898.SGD","BK0196","BK0236","LU1242518931.SGD","BK0096","BK0077","BK0114","BK0188"],"gpt_icon":0},{"id":"2534249134","title":"爱尔眼科新注册《爱尔医疗云平台1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2534249134","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534249134?lang=zh_cn&edition=full","pubTime":"2025-05-11 01:36","pubTimestamp":1746898572,"startTime":"0","endTime":"0","summary":"证券之星消息，近日爱尔眼科（300015）新注册了《爱尔医疗云平台1.0》项目的软件著作权。今年以来爱尔眼科新注册软件著作权9个。结合公司2024年年报财务数据，2024年公司在研发方面投入了3.21亿元，同比减3.86%。数据来源：企查查以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025051100000145.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0200","LU1242518857.USD","BK0096","159891","BK0196","BK0028","LU0979878070.USD","300015","BK0114","LU1146622755.USD","BK0012","BK0113","BK0188","LU1242518931.SGD","BK0236","LU1820825898.SGD"],"gpt_icon":0},{"id":"2533667627","title":"爱尔眼科：2024年并购的医院多为地县级医院，院龄较短、收入体量较小","url":"https://stock-news.laohu8.com/highlight/detail?id=2533667627","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533667627?lang=zh_cn&edition=full","pubTime":"2025-05-07 16:30","pubTimestamp":1746606639,"startTime":"0","endTime":"0","summary":"证券之星消息，爱尔眼科05月07日在投资者关系平台上答复投资者关心的问题。还是收购的医院尚未开业？2024年外部环境的复杂多变，基本医疗受医保影响，非基本医疗受经济影响。值得注意的是，2024年并购的医院多为地县级医院，院龄较短、收入体量较小，且只计入并表后的收入而非全年收入。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025050700024656.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300015","BK0200","LU0979878070.USD","LU1820825898.SGD","BK0236","LU1242518857.USD","BK0188","BK0096","BK0114","LU1242518931.SGD","BK0077","BK0113","BK0012","LU1146622755.USD","BK0028","BK0196"],"gpt_icon":0},{"id":"2533638117","title":"爱尔眼科624万限售股解除限售条件达成 暂不上市至11月5日","url":"https://stock-news.laohu8.com/highlight/detail?id=2533638117","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533638117?lang=zh_cn&edition=full","pubTime":"2025-05-06 18:29","pubTimestamp":1746527340,"startTime":"0","endTime":"0","summary":"5月6日，爱尔眼科（300015）发布公告，关于2021年限制性股票激励计划预留授予部分第三个解除限售期解除限售条件成就但股票暂不上市的情况。根据公告，解除限售的条件达成之日为2025年5月6日，符合解除限售条件的激励对象共计1,025名，解除限售的限制性股票数量为624万股，占公司目前总股本的0.0669%。所有激励对象均满足100%解除限售条件。尽管解除限售条件已达成，解除的限制性股票将暂不上市，继续禁售至2025年11月5日。2025年一季度，爱尔眼科实现收入60.26亿元，归母净利润10.50亿元。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/zqgd/2025-05-06/doc-inevrray2102965.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1146622755.USD","BK0077","BK0113","BK0188","BK0200","BK0096","LU1242518931.SGD","300015","BK0196","LU1820825898.SGD","BK0028","BK0012","BK0236","LU1242518857.USD","LU0979878070.USD","BK0114"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1754900414753,"stockEarnings":[{"period":"1week","weight":-0.0078},{"period":"1month","weight":0.0366},{"period":"3month","weight":0.0051},{"period":"6month","weight":-0.0141},{"period":"1year","weight":0.1935},{"period":"ytd","weight":-0.0245}],"compareEarnings":[{"period":"1week","weight":0.0211},{"period":"1month","weight":0.0407},{"period":"3month","weight":0.0877},{"period":"6month","weight":0.1003},{"period":"1year","weight":0.2666},{"period":"ytd","weight":0.0845}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"爱尔眼科医院集团股份有限公司","boardCode":"AI0083","boardName":"卫生","stockholders":"347329人(较上一季度减少8.39%)","perCapita":"22834股","listingDate":"2009-10-30","address":"湖南省长沙市天心区芙蓉南路一段188号爱尔大厦","registeredCapital":"932539万元","survey":" 爱尔眼科医院集团股份有限公司的主营业务是各类眼科疾病诊疗、手术服务与医学验光配镜。公司的主要产品是屈光项目、白内障项目、眼前段项目、眼后段项目、视光服务项目。","listedPrice":28},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.7","shortVersion":"4.34.7","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"爱尔眼科(300015)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供爱尔眼科(300015)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"爱尔眼科,300015,爱尔眼科股票,爱尔眼科股票老虎,爱尔眼科股票老虎国际,爱尔眼科行情,爱尔眼科股票行情,爱尔眼科股价,爱尔眼科股市,爱尔眼科股票价格,爱尔眼科股票交易,爱尔眼科股票购买,爱尔眼科股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"爱尔眼科(300015)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供爱尔眼科(300015)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}